Aberrant protein deposition and neurological disease - PubMed (original) (raw)

Review

. 1999 Dec 31;274(53):37507-10.

doi: 10.1074/jbc.274.53.37507.

Affiliations

• PMID: 10608801
• DOI: 10.1074/jbc.274.53.37507

Free article

Review

Aberrant protein deposition and neurological disease

M D Kaytor et al. J Biol Chem. 1999.

Free article

No abstract available

PubMed Disclaimer

Similar articles

• Editorial: Pathogenic templating proteins in Neurodegenerative Disease.
  Volpicelli-Daley L, Brundin P. Volpicelli-Daley L, et al. Neurobiol Dis. 2018 Jan;109(Pt B):175-177. doi: 10.1016/j.nbd.2017.11.004. Neurobiol Dis. 2018. PMID: 29249413 Free PMC article. No abstract available.
• Impaired clearance of oxidised proteins in neurodegenerative diseases.
  Halliwell B, Jenner P. Halliwell B, et al. Lancet. 1998 May 16;351(9114):1510. doi: 10.1016/S0140-6736(05)78898-X. Lancet. 1998. PMID: 9605824 No abstract available.
• Intrinsically unstructured proteins and neurodegenerative diseases: conformational promiscuity at its best.
  Das S, Mukhopadhyay D. Das S, et al. IUBMB Life. 2011 Jul;63(7):478-88. doi: 10.1002/iub.498. IUBMB Life. 2011. PMID: 21698751 Review.
• Analysis of protein aggregation in neurodegenerative disease.
  Pedersen JT, Heegaard NH. Pedersen JT, et al. Anal Chem. 2013 May 7;85(9):4215-27. doi: 10.1021/ac400023c. Epub 2013 Apr 4. Anal Chem. 2013. PMID: 23472885 Review.
• Neurodegenerative diseases linked to misfolded proteins and their therapeutic approaches: A review.
  Khanam H, Ali A, Asif M, Shamsuzzaman. Khanam H, et al. Eur J Med Chem. 2016 Nov 29;124:1121-1141. doi: 10.1016/j.ejmech.2016.08.006. Epub 2016 Aug 6. Eur J Med Chem. 2016. PMID: 27597727 Review.

Cited by

• Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice.
  Zu T, Duvick LA, Kaytor MD, Berlinger MS, Zoghbi HY, Clark HB, Orr HT. Zu T, et al. J Neurosci. 2004 Oct 6;24(40):8853-61. doi: 10.1523/JNEUROSCI.2978-04.2004. J Neurosci. 2004. PMID: 15470152 Free PMC article.
• Mutant Rab24 GTPase is targeted to nuclear inclusions.
  Maltese WA, Soule G, Gunning W, Calomeni E, Alexander B. Maltese WA, et al. BMC Cell Biol. 2002 Sep 25;3:25. doi: 10.1186/1471-2121-3-25. BMC Cell Biol. 2002. PMID: 12323076 Free PMC article.
• Attenuated nuclear shrinkage in neurones with nuclear inclusions of SCA1 brains.
  Nagaoka U, Uchihara T, Iwabuchi K, Konno H, Tobita M, Funata N, Yagishita S, Kato T. Nagaoka U, et al. J Neurol Neurosurg Psychiatry. 2003 May;74(5):597-601. doi: 10.1136/jnnp.74.5.597. J Neurol Neurosurg Psychiatry. 2003. PMID: 12700301 Free PMC article.
• Toward a molecular understanding of protein solubility: increased negative surface charge correlates with increased solubility.
  Kramer RM, Shende VR, Motl N, Pace CN, Scholtz JM. Kramer RM, et al. Biophys J. 2012 Apr 18;102(8):1907-15. doi: 10.1016/j.bpj.2012.01.060. Biophys J. 2012. PMID: 22768947 Free PMC article.
• Muscle atrophy and motor neuron degeneration in human NEDL1 transgenic mice.
  Zhang L, Haraguchi S, Koda T, Hashimoto K, Nakagawara A. Zhang L, et al. J Biomed Biotechnol. 2011;2011:831092. doi: 10.1155/2011/831092. Epub 2010 Oct 3. J Biomed Biotechnol. 2011. PMID: 20976258 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information